Apoptosis in coxsackievirus B3-caused diseases: Interaction between the capsid protein VP2 and the proapoptotic protein siva

Journal of Virology

Volumn 74, Issue 9, 2000, Pages 4284-4290

  Henke, Andreas ^a   Launhardt, Heike ^b   Klement, Katrin ^a   Stelzner, Axel ^a   Zell, Roland ^a   Munder, Thomas ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HANS KNÖLL INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; HEART; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MODEL; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; VIRUS PATHOGENESIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD27; ANTIGENS, CD70; APOPTOSIS; CAPSID; CAPSID PROTEINS; CARRIER PROTEINS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC;

EID: 0033993955     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.9.4284-4290.2000     Document Type: Article

References (52)

1. Agol, V. I., G. A. Belov, K. Bienz, D. Egger, M. S. Kolesnikova, N. T. Raikhlin, L. I. Romanova, E. A. Smirnova, and E. A. Tolskaya. 1998. Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis hut not cytopathic effect. Virology 252:343-353.
2. Badorff, C., G. H. Lee, B. J. Lamphear, M. E. Martone, K. P. Campbell, R. E. Rhoads, and K. U. Knowlton. 1999. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 5:320-326.
3. Barco, A., and L. Carrasco. 1995. Poliovirus 2Apro expression inhibits growth of yeast cells. FEBS Lett. 371:4-8.
4. Bartel, P., C. T. Chien, R. Sternglanz, and S. Fields. 1993. Elimination of false positives that arise in using the two-hybrid system. BioTechniques 14: 920-924.
5. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997 Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
6. Bowles, N. E., and J. A. Towbin. 1998. Molecular aspects of myocarditis. Curr. Opin. Cardiol. 13:179-184.
7. Breeden, L., and K. Nasmyth. 1985. Regulation of the yeast HO gene. Cold Spring Harbor Symp. Quant. Biol. 50:643-650.
8. Carthy, C. M., D. J. Granville, K. A. Watson, D. R. Anderson, J. E. Wilson, D. Yang, D. W. Hunt, and B. M. McManus. 1998. Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J. Virol. 72:7669-7675.
9. Chapman, N. M., Z. Tu, S. Tracy, and C. J. Gauntt. 1994. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch. Virol. 135:115-130.
10. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
11. Chow, L. H., K. W. Beisel, and B. M. McManus. 1992. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab. Investig. 66:24-31.
12. Colston, J. T., B. Chandrasekar, and G. L. Freeman. 1998. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis. Cardiovasc. Res. 38:158-168.
13. Doedens, J. R., and K. Kirkegaard. 1995. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 14:894-907.
14. Etchison, D., S. C. Milburn, I. Edery, N. Sonenberg, and J. W. Hershey. 1982. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 257:14806-14810.
15. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245-246.
16. Gebhard, J. R., C. M. Perry, S. Harkins, T. Lane, I. Mena, V. C. Asensio, I. L. Campbell, and J. L. Whitton. 1998. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am. J. Pathol. 153:417-428.
17. Gravestein, L. A., D. Amsen, M. Boes, C. R. Calvo, A. M. Kruisbeek, and J. Borst. 1998. The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2. Eur. J. Immunol. 28:2208-2216.
18. + T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69:6720-6728.
19. Hintzen, R. Q., S. M. Lens, G. Koopman, S. T. Pals, H. Spits, and R. A. van Lier. 1994. CD70 represents the human ligand for CD27. Int. Immunol. 6: 477-480.
20. Hsieh, T. Y., M. Matsumoto, H. C. Chou, R. Schneider, S. B. Hwang, A. S. Lee, and M. M. Lai. 1998. Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J. Biol. Chem. 273:17651-17659.
21. Huber, M., H. C. Selinka, and R. Kandolf. 1997. Tyrosine phosphorylation events during coxsackievirus B3 replication. J. Virol. 71:595-600.
22. Huber, S. A. 1997. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab. Investig. 76:691-701.
23. + T-cell responses in coxsackievirus B3-induced myocarditis in mice. J. Virol. 73:4689-95.
24. Huber, S. A., and P. A. Lodge. 1984. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am. J. Pathol. 116: 21-29.
25. + T-cell receptor. J. Virol. 70: 3039-3044.
26. Huber, S. A., and B. Pfaeffle. 1994. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J. Virol. 68:5126-5132.
27. + T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis. J. Virol. 73:5630-5636.
28. Irurzun, A., L. Perez, and L. Carrasco. 1993. Enhancement of phospholipase activity during poliovirus infection. J. Gen. Virol. 74:1063-1071.
29. Jelachich, M. L., and H. L. Lipton. 1999. Restricted Theiler's murine encephalomyelitis virus infection in murine macrophages induces apoptosis. J. Gen. Virol. 80:1701-1705.
30. Kandolf, R., and P. H. Hofschneider. 1985. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc. Natl. Acad. Sci. USA 82:4818-4822.
31. Kerekatte, V., B. D. Keiper, C. Badorff, A. Cai, K. U. Knowlton, and R. E. Rhoads. 1999. Cleavage of poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff? J. Virol. 73:709-717.
32. Khatib, R., J. L. Chason, B. K. Silberberg, and A. M. Lerner. 1980. Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: infectivity for myocardium and pancreas. J. Infect. Dis. 141:394-403.
33. Klebe, R. J., J. V. Harriss, Z. D. Sharp, and M. G. Douglas. 1983. A general method for polyethylene-glycol-induced genetic transformation of bacteria and yeast. Gene 25:333-341.
34. Klump, W. M., I. Bergmann, B. C Muller, D. Ameis, and R. Kandolf. 1990. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J. Virol. 64:1573-83.
35. Knowlton, K. U., E. S. Jeon, N. Berkley, R. Wessely, and S. Huber. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70:7811-7818.
36. Kräusslich, H. G., M. J. Nicklin, C. K. Lee, and E. Wimmer. 1988. Polyprotein processing in picornavirus replication. Biochemie 70:119-130.
37. Leipner, C., M. Borchers, I. Merkle, and A. Stelzner. 1999. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice. J. Hum. Virol. 2: 102-114.
38. Lindberg, A. M., R. L. Crowell, R. Zell, R. Kandolf, and U. Pettersson. 1992. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res. 24:187-196.
39. Lindberg, A. M., P. O. Stalhandske, and U. Pettersson. 1987. Genome of coxsackievirus B3. Virology 156:50-63.
40. MacDonald, P. N., D. R. Sherman, D. R. Dowd, S. C. Jefcoat, Jr., and R. K. DeLisle. 1995. The vitamin D receptor interacts with general transcription factor IIB. J. Biol. Chem. 270:4748-4752.
41. Ohlmann, T., M. Rau, V. M. Pain, and S. J. Morley. 1996. The C-terminal domain of eucaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independeni translation in the absence of eIF4E. EMBO J. 15:1371-1382.
42. Olivetti, G., R. Abbi, F. Quaini, J. Kajstura, W. Cheng, J. A. Nitahara, E. Quaini, C. Di Loreto, C. A. Beltrami, S. Krajewski, J. C. Reed, and P. Anversa. 1997. Apoptosis in the failing human heart. N. Engl. J. Med. 336: 1131-1141.
43. Padanilam, B. J., A. J. Lewington, and M. R. Hammerman. 1998. Expression of CD27 and ischemia/reperfusion-induced expression of its ligand Siva in rat kidneys. Kidney Int. 54:1967-1975.
44. Prasad, K. V., Z. Ao, Y. Yoon, M. X. Wu, M. Rizk, S. Jacquot, and S. F. Schlossman. 1997. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl. Acad. Sci. USA 94:6346-6351.
45. Reyes, M. P., and A. M. Lerner. 1985. Coxsackievirus myocarditis - with special reference to acute and chronic effects. Prog. Cardiovasc. Dis. 27: 373-394.
46. Tracy, S., N. M. Chapman, and Z. Tu. 1992. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch. Virol. 122:399-409.
47. van Kuppeveld, F. J., J. G. Hoenderop, R. L. Smeets, P. H. Willems, H. B. Dijkman, J. M. Galama, and W. J. Melchers. 1997. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO J. 16:3519-3532.
48. Wang, Y. F., S. C. Chen, F. Y. Wu, and C. W. Wu. 1997. The interaction between human cytomegalovirus immediate-early gene 2 (IE2) protein and heterogeneous ribonucleoprotein A1. Biochem. Biophys. Res. Commun. 232:590-594.
49. Woodruff, J. F. 1970. The influence of quantitated post-weaning undernutrition on coxsackievirus B3 infection of adult mice. II. Alteration of host defense mechanisms. J. Infect. Dis. 121:164-181.
50. Woodruff, J. F. 1980. Viral myocarditis. A review. Am. J. Pathol. 101:425-484.
51. Yang, D., J. Yu, Z. Luo, C. M. Carthy, J. E. Wilson, Z. Liu, and B. M. McManus. 1999. Viral myocarditis: identification of five differentially expressed genes in coxsackie-virus B3-infected mouse heart. Circ. Res. 84: 704-712.
52. Zell, R., and A. Stelzner. 1997. Application of genome sequence information to the classification of bovine enteroviruses: the importance of 5′- and 3′-nontranslated regions. Virus Res. 51:213-229.